PhRMA Advances Medicare Drug Pricing Challenge to Fifth Circuit

The leading pharmaceutical industry group is taking its challenge of a government drug price-setting program to a federal appeals court.

The Pharmaceutical Research and Manufacturers of America, along with the National Infusion Center Association and Global Colon Cancer Association, appealed to the US Court of Appeals for the Fifth Circuit on Wednesday a district court’s order that dismissed their lawsuit against the Medicare Drug Price Negotiation Program.

Judge David Alan Ezra of the US District Court for the Western District of Texas on Feb. 12 ruled the plaintiffs’ claims fell under the Medicare Act and didn’t satisfy the jurisdictional prerequisites. ...